SIBN
SI-BONE, Inc. · Healthcare · Medical - Devices
Todas las cifras de propiedad: únicamente gestores 13F seguidos, posiciones en acciones ordinarias, período de referencia Q2 2024
| Trimestre | Titulares | Δ | Acciones | Valor declarado | Nuevo | Cierres |
|---|---|---|---|---|---|---|
| Q2 2026 | 70 | -5 | 21.53M | $351.34M | +5 | −11 |
| Q1 2026 | 79 | +1 | 23.03M | $291.05M | +5 | −4 |
| Q4 2025 | 78 | 0 | 24.06M | $474.39M | — | — |
| Q3 2025 | 19 | +1 | 12.33M | $181.55M | +1 | — |
| Q2 2025 | 15 | +2 | 10.81M | $203.36M | +2 | — |
| Q1 2025 | 10 | +1 | 3.68M | $51.58M | +1 | — |
| Q4 2024 | 9 | +1 | 3.29M | $46.06M | +1 | — |
| Q3 2024 | 7 | -4 | 2.33M | $32.61M | — | −4 |
| Q2 2024 | 11 | — | 2.96M | $38.30M | — | — |
| # | Gestor | Acciones | Δ acciones | Valor | Su ponderación | Mantenida | ||
|---|---|---|---|---|---|---|---|---|
| 1 | Wellington Management ✦ | 993.02K | — | $12.84M | 0.0% | n/c | 1 | SEC ↗ |
| 2 | Wellington Management ✦ | 993.02K | — | $12.84M | 0.0% | n/c | 1 | SEC ↗ |
| 3 | Wellington Management ✦ | 993.02K | — | $12.84M | 0.0% | n/c | 1 | SEC ↗ |
| 4 | Wellington Management ✦ | 993.02K | — | $12.84M | 0.0% | n/c | 1 | SEC ↗ |
| 5 | Wellington Management ✦ | 993.02K | — | $12.84M | 0.0% | n/c | 1 | SEC ↗ |
| 6 | Geode Capital Management ✦ (pasivo) | 894.04K | — | $11.56M | 0.0% | n/c | 1 | SEC ↗ |
| 7 | Geode Capital Management ✦ (pasivo) | 894.04K | — | $11.56M | 0.0% | n/c | 1 | SEC ↗ |
| 8 | Millennium Management ✦ | 239.95K | — | $3.10M | 0.0% | n/c | 1 | SEC ↗ |
| 9 | Two Sigma Investments ✦ | 231.87K | — | $3.00M | 0.0% | n/c | 1 | SEC ↗ |
| 10 | Marshall Wace ✦ | 208.69K | — | $2.70M | 0.0% | n/c | 1 | SEC ↗ |
| 11 | Marshall Wace ✦ | 208.69K | — | $2.70M | 0.0% | n/c | 1 | SEC ↗ |
| 12 | Citadel Advisors ✦ | 156.95K | — | $2.03M | 0.0% | n/c | 1 | SEC ↗ |
| 13 | Renaissance Technologies ✦ | 130.70K | — | $1.69M | 0.0% | n/c | 1 | SEC ↗ |
| 14 | AQR Capital Management ✦ | 31.86K | — | $412,002 | 0.0% | n/c | 1 | SEC ↗ |
| 15 | AQR Capital Management ✦ | 31.86K | — | $412,002 | 0.0% | n/c | 1 | SEC ↗ |
| 16 | Bridgewater Associates ✦ | 30.86K | — | $398,994 | 0.0% | n/c | 1 | SEC ↗ |
| 17 | T. Rowe Price ✦ | 28.06K | — | $363,000 | 0.0% | n/c | 1 | SEC ↗ |
| 18 | D. E. Shaw & Co. ✦ | 15.79K | — | $204,229 | 0.0% | n/c | 1 | SEC ↗ |
«Su ponderación» = la participación de la posición en el valor de renta variable 13F declarado por ese gestor — la medida de convicción. ✦ = gestor seleccionado.
Nuevos compradores
| Sin nuevos compradores rastreados este trimestre. |
Posición cerrada
| Sin salidas rastreadas este trimestre. |
Contexto de mercado completo: entre TODOS los filers 13F (datos estructurados SEC, Q1 2026): 178 tenedores, 43.26M acciones, $537.87M declarado. Este es un período diferente y anterior al de las cifras del universo rastreado que figuran arriba, y ambos nunca se mezclan.
Qué otros valores suelen tener también los tenedores rastreados de este activo — recuentos de cotenencia, no relaciones fundamentales.
Compras en mercado abierto (P)
Sin compras en mercado abierto por parte de insiders en nuestra ventana de cobertura.
Ventas en mercado abierto (S)
Officer · 11.23K acc. · $224,785
Officer, Director · 3.92K acc. · $78,538
Officer, Director · 51.88K acc. · $1.01M
Officer · 5.75K acc. · $112,354
Officer, Director · 2.24K acc. · $41,772
Officer, Director · 1.97K acc. · $36,755
Officer, Director · 3.89K acc. · $72,616
Officer, Director · 3.65K acc. · $68,144
Officer, Director · 3.20K acc. · $59,778
Las adjudicaciones, ejercicios y retenciones fiscales nunca se contabilizan aquí como compras o ventas. Metodología